Visakhapatnam, September 15, 2025: In a landmark moment for India’s MedTech ecosystem, Dr. Ajay Sood, Principal Scientific Advisor to the Hon’ble Prime Minister of India Shri Narendra Modi, officially released the M.Tech and MBA curriculum of Erba Global MedTech University, Visakhapatnam.

The ceremony was graced by Dr. Jitendra Sharma, MD & CEO, Andhra Pradesh MedTech Zone (AMTZ); Mr. Rajiv Nath, Forum Coordinator, AiMeD; and Mr. Suresh Vazirani, Founder Chairman, Erba Transasia Group, along with senior faculty of the University. The Academic Council also reviewed upcoming Master’s and PhD programs, set to begin from January 2026.

Speaking on the occasion, Mr. Suresh Vazirani said: “This initiative marks yet another first in India and globally, driven by an excellent faculty team with great aspirations and motivation. The next generation of professionals will be eager to graduate from this pioneering institution, contributing significantly to the MedTech ecosystem.”

Aligned with Prime Minister, Narendra Modi’s vision of Atmanirbhar Bharat, the programs are designed to reduce dependency on imports, advance “Make in India” and “Skill India” missions, and position India as a global MedTech hub.

Located within AMTZ, the University provides students hands-on exposure with 150+ device manufacturers, backed by global collaborations with the WHO Collaborating Centre and World Trade Centre (WTC) AMTZ. The curriculum covers cutting-edge areas like AI-driven diagnostics, medical robotics, molecular diagnostics, and genomics, ensuring global standards while addressing India’s healthcare needs.

The newly launched curriculum is designed to:

•  Equip students with deep scientific and technical knowledge in medical technology
• Bridge the gap between research, industry, and entrepreneurship
• Develop leaders who will drive innovation in line with India’s “Make in India” and “Skill

  India” missions

• Contribute towards self-reliance in healthcare manufacturing and reduce dependence on

  imports

• Advanced curriculums focus on AI-driven medical diagnostics, medical robotics, molecular

  diagnostics, and cutting-edge genomics

• Covers international benchmarks (aligned with US/EU/FDA/WHO standards)
• Apt for doctors, engineers, medical technologists and students

  With this achievement, Erba Transasia once again stands at the forefront of building a healthier tomorrow—where education, innovation, and dedication come together to serve humanity.

  Incepted in the year 1979, Transasia Bio-Medicals Ltd., is headquartered in Mumbai, India. It is recognized as India’s Leading In-vitro Diagnostic Company and offers solutions and products in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management and Molecular Diagnostics.

Transasia Bio-Medicals manufactures and markets equipment and reagents, with an impressive install base of above 90,000 equipment across 50,000 laboratories in India. The vast network of more than 350 service engineers, 400+ sales and marketing team, 26 zonal offices, and 550+ channel partners allows us to reach out to over 5000 tier II-IV cities, towns and villages including the farthest north-eastern regions in a record time of just 4-5 hours. In fact, Transasia boasts of the largest team of sales and service personnel in the Indian IVD Industry!

Transasia has long endorsed the ‘Make in India’ concept, much before it actually came into existence! In fact it is the first Indian company to manufacture and export state-of-the-art blood analyzers and reagents, way back in the 1990s. The latest technologies from its European subsidiaries at Czech Republic, are adopted and customized in India at the five manufacturing facilities at Baddi, Daman, Sikkim, Mumbai and Visakhapatnam, to develop products and solutions that aid in timely diagnosis.

Transasia leaves no stone unturned in order to provide quality, accurate and affordable diagnostic solutions. Over 150 crore blood tests are done on a Transasia equipment every year benefitting more than 200 million people. In fact, >150 test every second is conducted on a Transasia product!